Northann Corp. 8-K Summary
Business Context and Reporting Period
Northann Corp. (NCL), an emerging growth company incorporated in Nevada, filed this Current Report on Form 8-K on April 16, 2025. The report addresses a regulatory notice received from NYSE Regulation regarding the Company's compliance with continued listing standards on the NYSE American LLC.
Key Financial Metrics
This filing is a notice of delinquency and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material event is the Company's failure to file its Form 10-K for the fiscal year ended December 31, 2024, by the extended deadline of April 15, 2025. This failure constitutes a "Filing Delinquency" under Sections 134 and 1101 of the NYSE American Company Guide. The Company previously notified the SEC of this delay via Form 12b-25 on March 31, 2025, citing the need for additional time to finalize consolidated financial statements and disclosures.
Outlook, Risks, and Contingencies
- Cure Period: The Company has been granted an initial six-month cure period to file the delinquent report and regain compliance.
- Delisting Risk: If the Company fails to file within the initial cure period, the Exchange may grant an additional six-month period. Failure to comply by the end of any cure period will likely result in suspension and delisting procedures.
- Discretionary Action: The Exchange reserves the right to truncate cure periods or immediately commence delisting if it deems continued listing inadvisable.
- Management Intent: Management intends to file the delinquent report as soon as practicable but offers no assurance that compliance will be achieved.
Investor Verification Checklist
- Verify the status of the Form 10-K for the year ended December 31, 2024, on the SEC EDGAR database.
- Monitor NYSE American announcements for any updates regarding the Company's cure period or potential delisting.
- Review the previously filed Form 12b-25 (dated March 31, 2025) for details on the specific accounting delays.
- Check for any subsequent 8-K filings regarding the resolution of the delinquency or changes in the cure timeline.